» Articles » PMID: 38567242

Comparative Analysis of Demographic and Clinical Findings in Spontaneous, Peritoneal Dialysis-Related, and Secondary Bacterial Peritonitis

Overview
Journal Cureus
Date 2024 Apr 3
PMID 38567242
Authors
Affiliations
Soon will be listed here.
Abstract

Background This study aims to contribute to peritonitis management strategies by comparing the demographic, clinical, and laboratory characteristics of patients diagnosed with spontaneous bacterial peritonitis (SBP), peritoneal dialysis-related peritonitis (PDrP), and secondary peritonitis. Methods This study included 86 patients diagnosed with peritonitis between 2016 and 2022. Patients were categorized and compared as SBP, PDrP, and secondary peritonitis. Results SBP was diagnosed in 36% of patients, secondary peritonitis in 36% and PDrP in 28%. The mean age of patients with PDrP is 43.71 ± 14.74, which is significantly lower compared to those with SBP and secondary peritonitis (p<0.001). Patients with hypertension (HT), chronic kidney disease (CKD), and those undergoing dialysis most commonly have PDrP whereas those without HT, without CKD, and not undergoing dialysis are most often diagnosed with secondary peritonitis (p=0.002, p<0.001, p<0.001). In peritoneal fluid cultures, the growth of Gram-positive bacteria was most commonly identified in patients with PDrP, while the growth of Gram-negative bacteria was most frequently seen in patients with secondary peritonitis (p=0.018). CRP levels and sedimentation rates were found to be higher in patients with secondary peritonitis (p<0.001, p=0.003). Conclusion The distinct characteristics observed across different types of peritonitis underscore the importance of tailored approaches to diagnosis and treatment. Parameters such as CRP levels, sedimentation rates, and patient age could serve as valuable indicators in discerning between various types of peritonitis. When selecting empirical antibiotic therapy, it's crucial to consider coverage for Gram-positive pathogens in cases of PDrP and Gram-negative pathogens in secondary peritonitis.

Citing Articles

Postoperative Outcomes Following Surgical Management of Secondary Peritonitis in a Referral Hospital in Eastern Venezuela.

Gonzalez-Guaimare R, Rivero Y, Hernandez-Velasquez A, Avila-Liendo E, Rivas-Perez M, Estrella-Gaibor C Cureus. 2024; 16(8):e68130.

PMID: 39347224 PMC: 11438491. DOI: 10.7759/cureus.68130.

References
1.
Lim W, Johnson D, McDonald S . Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton). 2005; 10(2):192-7. DOI: 10.1111/j.1440-1797.2005.00374.x. View

2.
Muthucumarana K, Howson P, Crawford D, Burrows S, Swaminathan R, Irish A . The Relationship Between esentation and the Time of Initial Administration of Antibiotics With utcoes of erionitis in Peritoneal Dialysis Patients: The PROMPT Study. Kidney Int Rep. 2017; 1(2):65-72. PMC: 5678844. DOI: 10.1016/j.ekir.2016.05.003. View

3.
Porner D, von Vietinghoff S, Nattermann J, Strassburg C, Lutz P . Advances in the pharmacological management of bacterial peritonitis. Expert Opin Pharmacother. 2021; 22(12):1567-1578. DOI: 10.1080/14656566.2021.1915288. View

4.
Groteluschen R, Heidelmann L, Lutgehetmann M, Melling N, Reeh M, Ghadban T . Antibiotic sensitivity in correlation to the origin of secondary peritonitis: a single center analysis. Sci Rep. 2020; 10(1):18588. PMC: 7596236. DOI: 10.1038/s41598-020-73356-x. View

5.
Al Sahlawi M, Wilson G, Stallard B, Manera K, Tong A, Pisoni R . Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020; 40(2):132-140. DOI: 10.1177/0896860819893810. View